Lenti-iCas9-neo vector (V017072)

Price Information

Cat No. Plasmid Name Availability Add to cart
V017072 Lenti-iCas9-neo In stock, 1 week for quality controls

Buy one, get one free!

Two tubes of lyophilized plasmid will be delivered, each tube is about 5µg.

Basic Vector Information

Vector Name:
Lenti-iCas9-neo
Antibiotic Resistance:
Ampicillin
Length:
15200 bp
Type:
Gene knockout
Replication origin:
ori
Host:
Mammalian cells, Lentivirus
Selection Marker:
Neo/G418
Promoter:
UbC
Growth Strain(s):
Stbl3
Growth Temperature:
37℃

Lenti-iCas9-neo vector Map

Lenti-iCas9-neo15200 bp7001400210028003500420049005600630070007700840091009800105001120011900126001330014000147003' LTRHIV-1 PsiRREgp41 peptideProtein TatcPPT/CTStetracycline response elementminimal CMV promoterattB1Cas9EGFPattB2HAUbC promoterrtTA-AdvancedIRESNeoR/KanRWPRE3' LTR (Delta-U3)AmpR promoterAmpRoriCAP binding sitelac promoterlac operatorM13 rev

Plasmid Protocol

1. Centrifuge at 5,000×g for 5 min.

2. Carefully open the tube and add 20 μl of sterile water to dissolve the DNA.

3. Close the tube and incubate for 10 minutes at room temperature.

4. Briefly vortex the tube and then do a quick spin to concentrate the liquid at the bottom. Speed is less than 5000×g.

5. Store the plasmid at -20 ℃.

6. The concentration of plasmid re-measurement sometimes differs from the nominal value, which may be due to the position of the lyophilized plasmid in the tube, the efficiency of the re-dissolution, the measurement bias, and adsorption on the wall of the tube, therefore, it is recommended to transform and extract the plasmid before using it

General Plasmid Transform Protocol

1. Take one 100μl of the competent cells and thaw it on ice for 10min, add 2μl of plasmid, then ice bath for 30min, then heat-shock it at 42℃ for 60s, do not stir, and then ice bath for 2min.

2. Add 900μl of LB liquid medium without antibiotics, and incubate at 37℃ for 45min (30℃ for 1-1.5 hours) with 180rpm shaking.

3. Centrifuge at 6000rpm for 5min, leave only 100μl of supernatant to resuspend the bacterial precipitate and spread it onto the target plasmid-resistant LB plate.

4. Invert the plate and incubate at 37℃ for 14h, or at 30℃ for 20h.

5. Pick a single colony into LB liquid medium, add the corresponding antibiotics, incubate at 220rpm for 14h, and extract the plasmid according to the experimental needs and the instructions of the plasmid extraction kit.

Lenti-iCas9-neo vector Sequence

LOCUS       V017072                15200 bp    DNA     circular SYN 01-JAN-1980
DEFINITION  Exported.
ACCESSION   V017072
VERSION     V017072
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 15200)
  AUTHORS   .
  TITLE     Direct Submission
FEATURES             Location/Qualifiers
     source          1..15200
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     LTR             1..634
                     /label="3' LTR"
                     /note="3' long terminal repeat (LTR) from HIV-1"
     misc_feature    681..806
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"
     misc_feature    1303..1536
                     /label="RRE"
                     /note="The Rev response element (RRE) of HIV-1 allows for
                     Rev-dependent mRNA export from the nucleus to the
                     cytoplasm."
     CDS             1721..1765
                     /label="gp41 peptide"
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
                     al., 2013)"
     CDS             1914..1955
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
                     /label="Protein Tat"
     misc_feature    2058..2175
                     /label="cPPT/CTS"
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     protein_bind    2230..2500
                     /label="tetracycline response element"
                     /note="contains seven copies of the tetracycline operator
                     tetO"
     promoter        2533..2571
                     /label="minimal CMV promoter"
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     protein_bind    2701..2725
                     /label="attB1"
                     /note="recombination site for the Gateway(R) BP reaction"
     CDS             2821..6921
                     /label="Cas9"
                     /note="Cas9 (Csn1) endonuclease from the Streptococcus
                     pyogenes Type II CRISPR/Cas system"
     CDS             7048..7764
                     /label="EGFP"
                     /note="enhanced GFP"
     protein_bind    complement(7772..7796)
                     /label="attB2"
                     /note="recombination site for the Gateway(R) BP reaction"
     CDS             7849..7875
                     /label="HA"
                     /note="HA (human influenza hemagglutinin) epitope tag"
     promoter        7961..9172
                     /label="UbC promoter"
                     /note="human ubiquitin C promoter"
     CDS             9231..9974
                     /label="rtTA-Advanced"
                     /note="improved tetracycline-controlled transactivator"
     misc_feature    10030..10603
                     /label="IRES"
                     /note="internal ribosome entry site (IRES) of the
                     encephalomyocarditis virus (EMCV)"
     CDS             10619..11410
                     /label="NeoR/KanR"
                     /note="aminoglycoside phosphotransferase"
     misc_feature    11590..12178
                     /label="WPRE"
                     /note="woodchuck hepatitis virus posttranscriptional
                     regulatory element"
     LTR             12253..12486
                     /label="3' LTR (Delta-U3)"
                     /note="self-inactivating 3' long terminal repeat (LTR) from
                     HIV-1"
     promoter        12691..12795
                     /label="AmpR promoter"
     CDS             12796..13653
                     /label="AmpR"
                     /note="beta-lactamase"
     rep_origin      13827..14415
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     protein_bind    14826..14847
                     /label="CAP binding site"
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     promoter        14862..14892
                     /label="lac promoter"
                     /note="promoter for the E. coli lac operon"
     protein_bind    14900..14916
                     /label="lac operator"
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be
                     relieved by adding lactose or
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     primer_bind     14924..14940
                     /label="M13 rev"
                     /note="common sequencing primer, one of multiple similar
                     variants"